Pancreatic Neuroendocrine Tumors Treatment in Turkey

Understanding Pancreatic Neuroendocrine Tumors and Symptoms

Pancreatic neuroendocrine tumours (pNETs) are neoplasms that originate in the hormone-producing endocrine (islet) cells of the pancreas. Unlike the more common pancreatic adenocarcinomas, which arise from the exocrine ducts, pNETs stem from neuroendocrine tissue and often exhibit distinct biological behaviour and growth rates. These tumours affect adults across a broad age range and require specialized care managed within Oncology programs.

The clinical presentation of pNETs depends largely on whether the tumour is functional or non-functional:

• Functional Tumours: These neoplasms actively secrete hormones into the bloodstream. Symptoms depend on the specific hormone overproduced. For example, insulinomas cause severe hypoglycaemia (low blood sugar), leading to dizziness, confusion, and sweating. Gastrinomas produce excess gastrin, causing severe peptic ulcers and chronic diarrhoea (Zollinger-Ellison syndrome). Glucagonomas may lead to high blood sugar levels and a distinct skin rash called necrolytic migratory erythema.
• Non-functional Tumours: These tumours do not produce active hormones and often go undetected until they reach a larger size. Symptoms typically stem from local mass effect, causing vague abdominal pain, back discomfort, jaundice (yellowing of the skin or eyes due to bile duct obstruction), or unexpected weight loss.

Diagnostic Steps and Required Medical Records

Accurate diagnosis and staging are vital for determining an appropriate treatment strategy. Patients seeking an assessment in Turkey will undergo structured testing coordinated by an oncology team alongside specialists in Gastroenterology and Endocrinology.

Diagnostic evaluations generally include high-resolution multiphasic CT scans or contrast-enhanced MRI to visualize the primary pancreatic mass and assess liver metastasis. Specialized functional imaging, such as Gallium-68 DOTATATE PET/CT, is widely used to map somatostatin receptor expression across the body. Blood tests measure specific tumour markers like Chromogranin A (CgA) and specific fasting hormone levels. Endoscopic ultrasound (EUS) may be performed to obtain detailed images and secure tissue biopsies.

Before travelling, patients should compile and bring the following medical records:

• Recent imaging scans (CT, MRI, PET) provided on CD/DVD alongside formal radiologist reports.
• Histopathology slides or paraffin blocks if a biopsy has already been conducted locally.
• Complete blood panel results, including liver function tests and relevant hormone markers.
• A detailed summary of medical history and past treatments from their home doctor.

Treatment Options for Pancreatic NETs

Treatment decisions depend on tumour grade (Ki-67 proliferation index), stage, functional status, and the patient's general health. Care plans are determined after thorough evaluation by a multidisciplinary tumor board.

Planning Treatment in Turkey and Post-Care

Planning international travel for pancreatic neuroendocrine tumor care requires structured preparation. Prior to arrival, medical records and diagnostic images are reviewed to establish a preliminary evaluation plan. Patients undergo additional diagnostic checks upon arrival to finalize the treatment strategy.

The length of stay in Turkey depends on the recommended intervention. Non-surgical consultations or initiation of medical therapies may require 5 to 7 days. If surgical intervention is advised, patients should plan for an inpatient hospital stay followed by 2 to 3 weeks of local recovery before flying home. Comprehensive discharge instructions will outline medication management, wound care, and dietary recommendations. Long-term follow-up and surveillance scans are coordinated with the patient's local medical team to ensure continuous monitoring.

Travel Precautions and Medical Warnings

International travel is not recommended for patients experiencing unstable hormone-related crises, severe uncontrolled hypoglycaemia, active deep vein thrombosis, or acute bowel obstruction. Flying immediately after major pancreatic surgery carries high risks of complications and should only occur once cleared by the operating surgical team.

Patients should seek urgent medical attention locally if they develop high fever, persistent vomiting, severe abdominal pain, sudden jaundice, or severe dizziness consistent with profound low blood sugar. Always confirm travel safety with your primary specialist before booking international arrangements.